Evidence map›Paper›PMID 42741190›Full record

ArticleComputational and structural biotechnology journal2026

Dual Modulation of Adipogenesis and Lipolysis Augments Facial Adipose Tissue Restoration.

Nayere Taebnia, Magdalena Murawska, Aurino M Kemas, Hongda Sheng, Yi Wang, Jian Xu, Tingting Zhou, Ivan Galanin, Volker M Lauschke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nayere TaebniaDepartment of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-0707-278X
Magdalena MurawskaABS Group Inc., Edmonton, AB, Canada.ORCID https://orcid.org/0000-0001-9777-2899
Aurino M KemasDepartment of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.
Hongda ShengPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Yi WangPharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
Jian XuDepartment of Dermatology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang Province 310009, China.ORCID https://orcid.org/0009-0002-0890-8665
Tingting ZhouShanghai Hepo Biotechnology Co., Ltd, 201210 Shanghai, China.
Ivan GalaninAdipeau Inc., New York, NY, USA.ORCID https://orcid.org/0000-0002-8991-9552
Volker M LauschkeDepartment of Physiology and Pharmacology and Center for Molecular Medicine, Karolinska Institutet and University Hospital, Stockholm, Sweden.ORCID https://orcid.org/0000-0002-1140-6204

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging leads to structural changes in facial adipose tissue, characterized by an imbalance between adipocyte regeneration and hypertrophy. Current therapeutic approaches primarily target individual aspects of these changes, often failing to address the dual nature of facial adipose remodeling. Using a combination of in vivo and ex vivo methods, we present a therapeutic strategy based on

Identifiers

PMID42741190
PMCPMC13572798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.